Cargando…
Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer
BACKGROUND: Phenoxodiol is a novel isoflavone currently being studied in clinical trials for the treatment of cancer. This study reports the pharmacokinetics of phenoxodiol in patients with cancer. METHODS: The pharmacokinetics of phenoxodiol was studied following a single intravenous (iv) bolus dos...
Autores principales: | Howes, Jan B, de Souza, Paul L, West, Leanne, Huang, Li Jiu, Howes, Laurence G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045896/ https://www.ncbi.nlm.nih.gov/pubmed/21291562 http://dx.doi.org/10.1186/1472-6904-11-1 |
Ejemplares similares
-
Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells
por: McPherson, R A C, et al.
Publicado: (2009) -
The effects of phenoxodiol on the cell cycle of prostate cancer cell lines
por: Mahoney, Simon, et al.
Publicado: (2014) -
Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro and in vivo
por: Georgaki, Sylvianna, et al.
Publicado: (2009) -
Synthesis of Dextran–Phenoxodiol and Evaluation of Its Physical Stability and Biological Activity
por: Yee, Eugene M. H., et al.
Publicado: (2019) -
Pharmacokinetics of esomeprazole following intravenous and oral administration in healthy dogs
por: Cook, Emily K, et al.
Publicado: (2016)